These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 22595458)
1. Targeted Casp8AP2 methylation increases drug resistance in mesenchymal stem cells and cancer cells. Lee KD; Pai MY; Hsu CC; Chen CC; Chen YL; Chu PY; Lee CH; Chen LT; Chang JY; Huang TH; Hsiao SH; Leu YW Biochem Biophys Res Commun; 2012 Jun; 422(4):578-85. PubMed ID: 22595458 [TBL] [Abstract][Full Text] [Related]
2. Hypermethylation of two CpG sites upstream of CASP8AP2 promoter influences gene expression and treatment outcome in childhood acute lymphoblastic leukemia. Li ZG; Jiao Y; Li WJ; Deng GR; Cui L; Gao C; Zhao XX; Wu MY; Jia HT Leuk Res; 2013 Oct; 37(10):1287-93. PubMed ID: 23953914 [TBL] [Abstract][Full Text] [Related]
3. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer. Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic regulation of death-associated protein kinase expression in primary gastric cancers from Chinese patients. Ye M; Li D; Zhou F; Guo Q; Xia B Eur J Cancer Prev; 2012 May; 21(3):241-6. PubMed ID: 21979297 [TBL] [Abstract][Full Text] [Related]
5. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene. Strathdee G; Davies BR; Vass JK; Siddiqui N; Brown R Carcinogenesis; 2004 May; 25(5):693-701. PubMed ID: 14729589 [TBL] [Abstract][Full Text] [Related]
6. Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance. Wilting RH; Dannenberg JH Drug Resist Updat; 2012; 15(1-2):21-38. PubMed ID: 22356866 [TBL] [Abstract][Full Text] [Related]
7. Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway. Kodach LL; Jacobs RJ; Voorneveld PW; Wildenberg ME; Verspaget HW; van Wezel T; Morreau H; Hommes DW; Peppelenbosch MP; van den Brink GR; Hardwick JC Gut; 2011 Nov; 60(11):1544-53. PubMed ID: 21551187 [TBL] [Abstract][Full Text] [Related]
8. Intermediate filament dynamics and breast cancer: aberrant promoter methylation of the Synemin gene is associated with early tumor relapse. Noetzel E; Rose M; Sevinc E; Hilgers RD; Hartmann A; Naami A; Knüchel R; Dahl E Oncogene; 2010 Aug; 29(34):4814-25. PubMed ID: 20543860 [TBL] [Abstract][Full Text] [Related]
9. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter. Sohn BH; Park IY; Lee JJ; Yang SJ; Jang YJ; Park KC; Kim DJ; Lee DC; Sohn HA; Kim TW; Yoo HS; Choi JY; Bae YS; Yeom YI Gastroenterology; 2010 May; 138(5):1898-908. PubMed ID: 20038433 [TBL] [Abstract][Full Text] [Related]
10. Promoter methylation-mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance. Narayan G; Freddy AJ; Xie D; Liyanage H; Clark L; Kisselev S; Un Kang J; Nandula SV; McGuinn C; Subramaniyam S; Alobeid B; Satwani P; Savage D; Bhagat G; Murty VV Genes Chromosomes Cancer; 2011 Dec; 50(12):1043-53. PubMed ID: 21960365 [TBL] [Abstract][Full Text] [Related]
11. Role of neurofilament light polypeptide in head and neck cancer chemoresistance. Chen B; Chen J; House MG; Cullen KJ; Nephew KP; Guo Z Mol Cancer Res; 2012 Mar; 10(3):305-15. PubMed ID: 22246235 [TBL] [Abstract][Full Text] [Related]
12. Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer. Soejima H; Nakagawachi T; Zhao W; Higashimoto K; Urano T; Matsukura S; Kitajima Y; Takeuchi M; Nakayama M; Oshimura M; Miyazaki K; Joh K; Mukai T Oncogene; 2004 May; 23(25):4380-8. PubMed ID: 15007390 [TBL] [Abstract][Full Text] [Related]
13. The temporal relationship between ABCB1 promoter hypomethylation, ABCB1 expression and acquisition of drug resistance. Reed K; Hembruff SL; Sprowl JA; Parissenti AM Pharmacogenomics J; 2010 Dec; 10(6):489-504. PubMed ID: 20125118 [TBL] [Abstract][Full Text] [Related]
14. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours. Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564 [TBL] [Abstract][Full Text] [Related]
15. IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer. Ibanez de Caceres I; Cortes-Sempere M; Moratilla C; Machado-Pinilla R; Rodriguez-Fanjul V; Manguán-García C; Cejas P; López-Ríos F; Paz-Ares L; de CastroCarpeño J; Nistal M; Belda-Iniesta C; Perona R Oncogene; 2010 Mar; 29(11):1681-90. PubMed ID: 20023704 [TBL] [Abstract][Full Text] [Related]
16. Correlation between methylation profile of promoter cpg islands of seven metastasis-associated genes and their expression states in six cell lines of liver origin. Li JL; Fei Q; Yu J; Zhang HY; Wang P; Zhu JD Ai Zheng; 2004 Sep; 23(9):985-91. PubMed ID: 15363188 [TBL] [Abstract][Full Text] [Related]
17. Homo sapiens lactate dehydrogenase c (Ldhc) gene expression in cancer cells is regulated by transcription factor Sp1, CREB, and CpG island methylation. Tang H; Goldberg E J Androl; 2009; 30(2):157-67. PubMed ID: 18930904 [TBL] [Abstract][Full Text] [Related]
18. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer. Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112 [TBL] [Abstract][Full Text] [Related]
19. Epigenetic changes in cancer and preneoplasia. Herman JG Cold Spring Harb Symp Quant Biol; 2005; 70():329-33. PubMed ID: 16869769 [TBL] [Abstract][Full Text] [Related]
20. Epigenetic alterations by methylation of RASSF1A and DAPK1 promoter sequences in mammary carcinoma detected in extracellular tumor DNA. Ahmed IA; Pusch CM; Hamed T; Rashad H; Idris A; El-Fadle AA; Blin N Cancer Genet Cytogenet; 2010 Jun; 199(2):96-100. PubMed ID: 20471512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]